Crossmark

A randomized controlled trial to examine the impacts of disclosing personalized depression risk information on the outcomes of individuals who are at high risk of developing major depression: a research protocol

Crossref DOI link: https://doi.org/10.1186/s12888-019-2270-9

Published Online: 2019-09-18

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, JianLi https://orcid.org/0000-0002-1329-914X
MacQueen, Glenda

Patten, Scott

Manuel, Douglas

Lashewicz, Bonnie

Schmitz, Norbert
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research
License Information

Text and Data Mining valid from 2019-09-18

Version of Record valid from 2019-09-18
More Information

Article History

Received: 23 July 2019

Accepted: 3 September 2019

First Online: 18 September 2019

Ethics approval and consent to participate

: The eligible participants are located across the country. Written informed consent is not feasible. We obtained verbal consent prior to the telephone interview. This study has been approved by the Ethics Review Board of the Royal Hospital, Ottawa, Canada.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below